Matches in SemOpenAlex for { <https://semopenalex.org/work/W2324841173> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2324841173 endingPage "391" @default.
- W2324841173 startingPage "391.2" @default.
- W2324841173 abstract "<h3>Objectives</h3> To assess the impact of Tocilizumab on bone oedema in rheumatoid arthritis as shown by MRI <h3>Methods</h3> In this longitudinal study, were included patients with rheumatoid arthritis RA according to the American College of Rheumatology ACR 1987 criteria with inadequate response or intolerance to DMARDs, treated with tocilizumab (TCZ).Sociodemographic characteristics, clinical and laboratory for the disease were collected at baseline (M0) and 06 months (M6) of treatment.Disease activity was assessed using DAS28, SDAI et CDAI.MRI of the dominant hand was performed at baseline and M6 of treatment.The primary outcome was the assessment of bone oedema by RAMRIS bone oedema (Rheumatoid Arthritis MRI Scoring system).Secondary outcomes included:RAMRIS synovitis, DAS28 CRP, CRP, and SDAI at baseline and M6. <h3>Results</h3> 22 patients with RA were included, 19 females (86.4%), with a mean of age 42±13.7. The mean disease duration was 8±5.2 years.The mean DAS28 was 5.8±0.94. The median CRP was 16 mg/l (6.7 to 36.3). The average SDAI was 90±34. Three patients were excluded from the study for serious side effects.At baseline, bone edema was present in 41% of patients (N=9), with a median bone oedema RAMRIS 0 (0 to 7.2). A M6, bone oedema decreased or disappeared in 32% (N=7) with a significant improvement in the score RAMRIS bone oedema (p=0.04). Moreover, there is a significant improvement RAMRIS synovitis (p<0.0001) as well as activity parameters: DAS28CRP (p <o, ooo1), CRP (p<0.0001) and SDAI (p<0.0001). <h3>Conclusions</h3> This study suggests that Tocilizumab is associated with a significant improvement in MRI- determined bone oedema in the short term. This improvement in bone oedema is correlated with improved parameters of disease activity, which could be discussed early structural effect. Further studies are needed to confirm these results. <h3>Disclosure of Interest</h3> None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.5921" @default.
- W2324841173 created "2016-06-24" @default.
- W2324841173 creator A5023792659 @default.
- W2324841173 creator A5024042421 @default.
- W2324841173 creator A5034212319 @default.
- W2324841173 creator A5041468862 @default.
- W2324841173 creator A5044230339 @default.
- W2324841173 creator A5057012843 @default.
- W2324841173 date "2014-06-01" @default.
- W2324841173 modified "2023-10-18" @default.
- W2324841173 title "FRI0028 Efficacy of TOCILIZUMAB on MRI- Determined Bone Oedema in Rheumatoid Arthritis" @default.
- W2324841173 doi "https://doi.org/10.1136/annrheumdis-2014-eular.5921" @default.
- W2324841173 hasPublicationYear "2014" @default.
- W2324841173 type Work @default.
- W2324841173 sameAs 2324841173 @default.
- W2324841173 citedByCount "0" @default.
- W2324841173 crossrefType "journal-article" @default.
- W2324841173 hasAuthorship W2324841173A5023792659 @default.
- W2324841173 hasAuthorship W2324841173A5024042421 @default.
- W2324841173 hasAuthorship W2324841173A5034212319 @default.
- W2324841173 hasAuthorship W2324841173A5041468862 @default.
- W2324841173 hasAuthorship W2324841173A5044230339 @default.
- W2324841173 hasAuthorship W2324841173A5057012843 @default.
- W2324841173 hasConcept C126322002 @default.
- W2324841173 hasConcept C141071460 @default.
- W2324841173 hasConcept C198451711 @default.
- W2324841173 hasConcept C2777178219 @default.
- W2324841173 hasConcept C2777575956 @default.
- W2324841173 hasConcept C2779244835 @default.
- W2324841173 hasConcept C71924100 @default.
- W2324841173 hasConceptScore W2324841173C126322002 @default.
- W2324841173 hasConceptScore W2324841173C141071460 @default.
- W2324841173 hasConceptScore W2324841173C198451711 @default.
- W2324841173 hasConceptScore W2324841173C2777178219 @default.
- W2324841173 hasConceptScore W2324841173C2777575956 @default.
- W2324841173 hasConceptScore W2324841173C2779244835 @default.
- W2324841173 hasConceptScore W2324841173C71924100 @default.
- W2324841173 hasIssue "Suppl 2" @default.
- W2324841173 hasLocation W23248411731 @default.
- W2324841173 hasOpenAccess W2324841173 @default.
- W2324841173 hasPrimaryLocation W23248411731 @default.
- W2324841173 hasRelatedWork W1984273828 @default.
- W2324841173 hasRelatedWork W1987294331 @default.
- W2324841173 hasRelatedWork W2046399730 @default.
- W2324841173 hasRelatedWork W2086657643 @default.
- W2324841173 hasRelatedWork W2123582592 @default.
- W2324841173 hasRelatedWork W2736593664 @default.
- W2324841173 hasRelatedWork W2925118230 @default.
- W2324841173 hasRelatedWork W2996380604 @default.
- W2324841173 hasRelatedWork W4239841759 @default.
- W2324841173 hasRelatedWork W2065293415 @default.
- W2324841173 hasVolume "73" @default.
- W2324841173 isParatext "false" @default.
- W2324841173 isRetracted "false" @default.
- W2324841173 magId "2324841173" @default.
- W2324841173 workType "article" @default.